Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATMOSPHERE: Aliskiren in chronic heart failure
NCT00853658Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 44
01
Overview
A Phase 3 trial of aliskiren in chronic heart failure (CHF), sponsored by Novartis. Started Mar 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00853658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853658.